Victoria Metaxa

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop et al. · The Lancet · 2020 · 344 citations · Full text

Hematological Malignancy, Cell Therapy, Transplantation +9

Communication and Virtual Visiting for Families of Patients in Intensive Care during the COVID-19 Pandemic: A UK National Survey

Louise Rose, Lisa Yu, Joseph Casey et al. · Annals of the American Thoracic Society · 2021 · 210 citations · Full text

Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks

Alexander Supady, J. Randall Curtis, Darryl Abrams et al. · The Lancet Respiratory Medicine · 2021 · 134 citations · Full text

The Speaker Gender Gap at Critical Care Conferences

Sangeeta Mehta, Louise Rose, Margaret S. Herridge et al. · Critical Care Medicine · 2018 · 132 citations · Full text

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus et al. · The Lancet Haematology · 2022 · 121 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +10